Abstract
Cardiovascular disease (CVD) is a major public health problem in many societies. Several types of CVD have a genetic basis or at least a genetic component. It has been estimated that about 50% of the variability of the major risk factors for coronary artery disease (CAD) is genetic. Environmental factors, such as diet, also influence CVD, and may in fact interact with genetic factors to modulate risk. The genes encoding the majority of structural and enzymatic proteins involved in lipid and lipoprotein metabolism have been cloned and characterized, permitting the use of molecular biology techniques to further our understanding of lipid and lipoprotein disorders. Coagulation factors have been implicated in thrombosis and thrombolysis, and a number of mutations and polymorphisms have been described that predispose to vascular disease. The focus of this chapter is to discuss these genetic factors related to atherosclerosis and hemostasis. The laboratory currently plays an important role in the battle against CVD by providing accurate and reliable measurement of lipids, lipoprotein cholesterols, and coagulation factors. With these important new discoveries, it is evident that the laboratory of the future will play a major role in screening, diagnosis, and treatment of familial lipoprotein abnormalities and CVD.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Beaudet, A. L., Scriver, C. R., Sly, W. S., Valle, D., Cooper, D. N., McKusick, V. A., and Schmidke, J. Genetics and biochemistry of variant human phenotypes, in The Metabolic Basis of Inherited Disease, Scriver, C. R., Beaudet, A. L., Sly, W. S., Valle, D., eds., McGraw Hill, New York, pp. 3–53, 1989.
Bazunga, M. The use of angiotensin converting enzyme inhibitors in asymptomatic patients with left ventricular dysfunction after myocardial infarction. Conn. Med. 59:663–666, 1995.
Brunzell, J. D. Familial lipoprotein lipase deficiency and other causes of the chylo-micronemia syndrome, in The Metabolic Basis ofInherited Disease, Scriver, C. R., Beaudet, A. L., Sly, W. S., Valle, D., eds., McGraw Hill, New York, pp. 1165–1180, 1989.
Schaefer, E. J. Familial lipoprotein disorders and premature coronary artery disease. Med. Clin. North Am. 78:21–39, 1994.
Brown, M. S. and Goldstein, J. L. A receptor-mediated pathway for cholesterol homeosta-sis. Science 232:34–47, 1986.
Genest, J. J., Jr., Martin-Munley, S. S., McNamara, J. R., Ordovas, J. M., Jenner, J., Myers, R. H., Silberman, S. R., Wilson, P. W. F., Salem, D. N., and Schaefer, E. J. Familial lipoprotein disorders in patients with premature coronary artery disease. Circulation 85:2025–2033, 1992.
Knecht, T. P. and Glass, C. K. The influence of molecular biology on our understanding of lipoprotein metabolism and the pathobiology of atherosclerosis. Ad. Genet. 32:141–198, 1995.
Kane, J. P. and Havel, R. J. Disorders of the biogenesis and secretion of lipoproteins containing the B apolipoprotein, in The Metabolic Basis ofInherited Disease, Scriver, C. R., Beaudet, A. L., Sly, W. S., and Valle, D., eds., McGraw Hill, New York, pp. 1139–1164, 1989.
Austin, M. A., Breslow, J. L., Hennekens, C. H, Buring, J. E., Willett, W. C., and Krauss, R. M. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 260:1917–1921, 1988.
Breslow, J. L. Familial disorders of high density lipoprotein metabolism, in The Meta-bolic Basis ofInherited Disease, Scriver, C. R., Beaudet, A. L., Sly, W. S., and Valle, D., eds., McGraw Hill, 1989.
Assman, G., Schmitz, G., and Brewer, H. B., Jr. Familial high density lipoprotein defi-ciency, in The Metabolic Basis ofInherited Disease, Scriver, C. R., Beaudet, A. L., Sly, W. S., and Valle, D., eds. McGraw Hill, New York, pp. 1251–1266, 1989.
Mahley, R. W. and Rall, S. C., Jr. Type III hyperlipoproteinemia (dysbetalipoproteinemia): the role of apolipoprotein E in normal and abnormal lipoprotein metabolism, in The Meta-bolic Basis ofInherited Disease, Scriver, C. R., Beaudet, A. L., Sly, W. S., and Valle, D., eds., McGraw Hill, New York, pp. 1267–1282, 1989.
Contois, J. H., Anamani, D. E., and Tsongalis, G. J. The underlying molecular mechanism od apolipoprotein E polymorphism: relationships to lipid disorders, cardiovascular dis-ease, and Alzheimer’ s disease. Clin. Lab. Med. 16:105–123, 1996.
Rosenberg, R. D. and Aird, W. C. Thrombosis, in Molecular Cardiovascular Medicine, Haber, E., ed., Scientific American, New York, pp. 115–132, 1995.
Tuddenham, E. G. D. and Cooper, D. N. The Molecular Genetics ofHaemostasis and its Inherited Disorders, section V. Oxford University Press, 1994.
Green, F. and Humphries, S. E. Genetic determinants of arterial thrombosis. Baillière’ s Clin. Haemotol. 7:675–692, 1994.
Cooper, D. N. The molecular genetics of familial venous thrombosis. Baillière’ s Clin. Haematol. 7:637–673, 1994.
Dahlbäck B. Inherited thrombophilia: resistance to activated protein C as a pathogenic factor of venous thromboembolism. Blood 85:607–614, 1995.
Bertina, R. M., Koeleman, B. P. C., Koster, T., Rosendaal, F. R., Driven, R. J., deRonde, H., van der Velden, P. A., and Reitsma, P. H. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369:64–67, 1995.
Dahlbäck B. Molecular genetics of thrombophilia: factor V gene mutation causing resis-tance to activated protein C as a basis of the hypercoagulable state. J. Lab. Clin. Med. 125:566–571. 1995.
Rosendaal, F. R., Koster, T., Vandenbroucke, J. P., and Reitsma, P. H. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood 85:1504–1508, 1995.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media New York
About this chapter
Cite this chapter
Contois, J.H., Huang, J.C. (1997). Molecular Pathogenesis of Cardiovascular Disease. In: Coleman, W.B., Tsongalis, G.J. (eds) Molecular Diagnostics. Pathology and Laboratory Medicine. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-4757-2588-9_13
Download citation
DOI: https://doi.org/10.1007/978-1-4757-2588-9_13
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4757-2590-2
Online ISBN: 978-1-4757-2588-9
eBook Packages: Springer Book Archive